Suppr超能文献

心脏基质重塑的计算病理学评估:心脏移植中的临床相关性及预后意义

Computational pathology assessments of cardiac stromal remodeling: Clinical correlates and prognostic implications in heart transplantation.

作者信息

Peyster Eliot G, Yuan Cai, Arabyarmohammadi Sara, Lal Priti, Feldman Michael D, Fu Pingfu, Margulies Kenneth B, Madabhushi Anant

机构信息

Cardiovascular Research Institute, University of Pennsylvania, Philadelphia, Pennsylvania.

Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Atlanta, Georgia.

出版信息

JHLT Open. 2024 Dec 28;7:100202. doi: 10.1016/j.jhlto.2024.100202. eCollection 2025 Feb.

Abstract

BACKGROUND

The hostile immune environment created by allotransplantation can accelerate pathologic tissue remodeling. Both overt and indolent inflammatory insults propel this remodeling, but there is a paucity of tools for monitoring the speed and severity of remodeling over time.

METHODS

This retrospective cohort consisted of  = 2,167 digitized heart transplant biopsy slides along with records of prior inflammatory events and future allograft outcomes (cardiac death or allograft vasculopathy). Utilizing computational pathology analysis, biopsy images were analyzed to identify the pathologic stromal changes associated with future allograft loss or vasculopathy. Biopsy images were then analyzed to assess which historical inflammatory events drive progression of these pathologic stromal changes.

RESULTS

The top 5 features of pathologic stromal remodeling most associated with adverse allograft outcomes were also strongly associated with histories of both overt and indolent inflammatory events. Compared to controls, a history of high-grade or treated rejection was significantly associated with progressive pathologic remodeling and future adverse outcomes (32.9% vs 5.1%,  < 0.001). A history of recurrent low-grade rejection and Quilty lesions was also significantly associated with pathologic remodeling and adverse outcomes vs controls (12.7% vs 5.1%,  = 0.047). A history of high-grade or treated rejection in the absence of recurrent low-grade rejection history was not associated with pathologic remodeling or adverse outcomes (7.1% vs 5.1%,  = 0.67).

CONCLUSIONS

A history of both traditionally treated and traditionally ignored alloimmune responses can predispose patients to pathologic allograft remodeling and adverse outcomes. Computational pathology analysis of allograft stroma yields translationally relevant biomarkers, identifying accelerated remodeling before adverse outcomes occur.

DATA AVAILABILITY

The data that support the findings of this study are presented in the manuscript and extended data sections. Unprocessed raw data are available from the corresponding author upon reasonable request. Source code for the stromal feature analysis pipeline is hosted on GitHub and freely available: https://github.service.emory.edu/CYUAN31/Pathomics_StromalBioMarker_in_Myocardium.git.

摘要

背景

同种异体移植所产生的敌对免疫环境可加速病理性组织重塑。明显的和隐匿的炎症损伤均推动这种重塑过程,但用于长期监测重塑速度和严重程度的工具却很匮乏。

方法

本回顾性队列研究纳入了2167份数字化心脏移植活检切片,以及既往炎症事件记录和未来移植物结局(心脏死亡或移植物血管病变)。利用计算病理学分析,对活检图像进行分析,以识别与未来移植物丢失或血管病变相关的病理性基质变化。然后对活检图像进行分析,以评估哪些既往炎症事件推动了这些病理性基质变化的进展。

结果

与移植物不良结局最相关的病理性基质重塑的前5个特征,也与明显的和隐匿的炎症事件史密切相关。与对照组相比,高级别或经治疗的排斥反应史与进行性病理性重塑和未来不良结局显著相关(32.9% 对5.1%,P<0.001)。复发性低级别排斥反应和奎尔蒂病变史与病理性重塑和不良结局也显著相关,与对照组相比(12.7% 对5.1%,P=0.047)。在无复发性低级别排斥反应史的情况下,高级别或经治疗的排斥反应史与病理性重塑或不良结局无关(7.1% 对5.1%,P=0.67)。

结论

传统上得到治疗的和被忽视的同种异体免疫反应史,均可使患者易于发生病理性移植物重塑和不良结局。对移植物基质进行计算病理学分析可产生具有转化意义的生物标志物,在不良结局出现之前识别加速的重塑过程。

数据可用性

支持本研究结果的数据已在论文和扩展数据部分中列出。可根据合理要求向通讯作者索取未处理的原始数据。基质特征分析流程的源代码托管在GitHub上,可免费获取:https://github.service.emory.edu/CYUAN31/Pathomics_StromalBioMarker_in_Myocardium.git。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ae66/11935495/8e65547b6d27/gr1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验